We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GLE:EURONEXT PARISSociete Generale S.A. Class A Analysis

Data as of 2026-05-19 - not real-time

$0.38

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Global Engine Group Holding Limited (GLE) is trading at $0.38, well below its 20‑day SMA of $0.41 and 50‑day SMA of $0.40, with a neutral RSI of 46 and a bearish MACD histogram indicating short‑term momentum weakness. Revenue has collapsed by 85% YoY, and the company is posting a -1.43 operating margin and a -0.25 profit margin, resulting in negative EPS and a -9.2 M free cash flow. Despite a low price‑to‑book of 0.85 and a price‑to‑sales of 0.30, the balance sheet shows negligible debt (debt‑to‑equity 0.001) but a concerning cash burn and negative operating cash flow. Volatility is extreme at 186% over 30 days, beta is 1.25, and the historical max drawdown exceeds 92%, underscoring a highly unstable price profile. The market cap is only $6.9 M, indicating limited liquidity, and the recent news of a securities class‑action investigation adds a layer of regulatory uncertainty.
Given the confluence of deteriorating fundamentals, aggressive price volatility, and pending legal scrutiny, the stock appears fundamentally distressed and unlikely to deliver upside without a significant turnaround or resolution of the investigation.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Bearish MACD and price below short‑term moving averages
  • Negative earnings and cash flow
  • High volatility and low liquidity

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Continued revenue decline and operating losses
  • Ongoing securities class‑action investigation
  • Elevated beta and sector competition

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential for restructuring given negligible debt
  • Low price‑to‑book may attract value investors if turnaround occurs
  • Uncertainty around legal outcome limits upside

Key Metrics & Analysis

Financial Health

Revenue Growth-85.30%
Profit Margin-25.30%
ROE-15.07%
ROA-8.38%
Debt/Equity0.00
P/B Ratio0.8
Op. Cash Flow$-9204049
Free Cash Flow$-18157072
Industry P/E38.0

Technical Analysis

TrendNeutral
RSI45.9
Support$0.31
Resistance$0.75
MA 20$0.41
MA 50$0.40
MA 200$0.53
MACDBearish
VolumeIncreasing
Fear & Greed Index89.25

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta1.25
Volatility185.62%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.